D
Cytokinetics, Incorporated CYTK
$38.34 $0.290.76% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 2,635.74% 412.21% 145.34% -58.81% -68.51%
Total Other Revenue -- -- -- -- --
Total Revenue 2,635.74% 412.21% 145.34% -58.81% -68.51%
Cost of Revenue 18.85% 7.65% 2.81% 3.31% 9.42%
Gross Profit 6.34% -3.03% 0.51% -4.86% -12.10%
SG&A Expenses 34.08% 34.07% 24.02% 7.43% -5.76%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 24.25% 16.57% 10.12% 4.81% 3.51%
Operating Income -8.08% -13.59% -8.07% -5.81% -5.00%
Income Before Tax -11.19% -15.96% -12.03% -9.43% -1.05%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -11.19% -15.96% -12.03% -9.43% -1.05%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -11.19% -15.96% -12.03% -9.43% -1.05%
EBIT -8.08% -13.59% -8.07% -5.81% -5.00%
EBITDA -9.01% -14.53% -8.76% -4.61% -3.78%
EPS Basic 4.66% 1.75% 3.20% 2.39% 5.62%
Normalized Basic EPS 4.66% 1.75% 3.20% 2.40% 1.52%
EPS Diluted 4.66% 1.75% 3.20% 2.39% 5.62%
Normalized Diluted EPS 4.66% 1.75% 3.20% 2.40% 1.52%
Average Basic Shares Outstanding 16.59% 17.99% 15.77% 12.12% 7.10%
Average Diluted Shares Outstanding 16.59% 17.99% 15.77% 12.12% 7.10%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --